Charlotte's Web Holdings, Inc. established a convertible Promissory Note with DeFloria valued at $1,582,500. This arrangement enhances the company’s funding opportunities to further support growth initiatives.
Key Highlights
- The Convertible Promissory Note totals $1,582,500, superseding a prior note from July 2025.
- The initial Interest Rate for the Note is set at 11.25%, with a maximum cap of 14%.
- A conversion option allows the company to choose preferred stock upon maturity, linked to a valuation cap of $146 million.
Charlotte's Web Holdings, Inc. (OTC: CWBHF) recently confirmed its arrangement regarding a $1,582,500 Convertible Promissory Note with DeFloria, effective August 14, 2026. This new agreement replaces a previous Loan issued on July 15, 2025, which tallied $750,000 alongside an accumulated interest of $82,500. The new note, part of a structured financing under the Convertible Note Purchase Agreement initiated on February 12, 2024, distinctly positions the company to access necessary funds for its ongoing initiatives through this financial collaboration with DeFloria.
The arrangement illustrates a notable enhancement in financial support available for Charlotte's Web to deploy in its operations and growth strategies.
Mechanics of the Note
The Convertible Promissory Note operates at a non-compounding interest rate of 8.0%, calculated alongside the Bank of England Base Rate from the first day of each quarter. Initially, the interest rate stands at 11.25%, eventually capping at 14% to maintain a balance between investor returns and the company's financial strategy. This note is unsecured and will mature either 90 days post-demand from the majority of note holders or upon certain triggering events categorized as defaults.
The specific terms aim to provide Charlotte's Web a pathway to engage with potential future investors, boosting Liquidity to support ongoing operational maneuvers. Prepayment is restricted without the approval of majority holders, which aligns with risk management principles in financing arrangements.
Significance of Timing
The establishment of this financing deal reflects a strategic initiative for Charlotte's Web as it navigates through evolving market dynamics. By securing this convertible note, the company not only maximizes potential advantages from interest rates but also positions itself proactively should DeFloria engage in further financing round aiming for at least $10 million, triggering favorable conversion terms. The imposed valuation cap of $146 million serves to reassure current Stakeholders about the company's financial outlook and operational performance.
Timing is critical as this move enables the company to remain competitive and Capitalize on emerging opportunities within its sector, ensuring strong engineering of growth strategies.
Future Developments to Monitor
Investors should monitor Charlotte's Web's Quarterly Report projected for September 30, 2026, as it will include detailed insights into the new financing’s performance and implications for overall financial health. The report will also address how the proceeds from the newly established note are allocated toward strategic priorities and further operational investments. The management's actions in subsequent periods regarding the potential conversion of Debt into Equity would be key in illustrating the company’s trajectory in leveraging its agreements for maximum operational advancements.
Peers Moving on This News
- Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) up 2.8%
- Rani Therapeutics Holdings Inc (NASDAQ: RANI) little changed
- Polaryx Therapeutics, Inc (NASDAQ: PLYX) down 3.7%






Please wait processing your request...